Partnership enables remote cancer care
Digital cancer care platform Careology and LloydsPharmacy Clinical Homecare, which provides home chemotherapy, have joined forces to monitor remotely patients undergoing cancer treatment at home.
Using an app on the patient’s phone or tablet, which communicates with wearable tech devices, clinicians can see patients’ symptoms, side effects, medication adherence and a range of other biometrics markers. This allows patients to receive treatment at home with nurses and consultants remotely monitoring them.
Jo Upton, deputy head of nursing of LloydsPharmacy Clinical Homecare, said: “Receiving cancer treatment is an incredibly challenging experience. We believe that having chemotherapy, delivered one-on-one by an experienced nurse in the comfort of your own home, coupled with the enhanced care and safety the platform provides, would make such a difference to our patients’ lives.”
“We are always looking at meaningful ways to improve the experience for our patients and their families. Equipping those undergoing treatment with new technology will give our nurses greater insight into how their patients are coping. It also empowers those they care for to self-manage in between treatment, promoting their safety and overall wellbeing.”
Paul Landau, founder and chief executive of Careology, added: “Technology has a crucial role to play in helping healthcare providers deliver effective, scalable cancer care, whilst enhancing patient safety and improving the patient experience. Having instant access to this in-depth, real-time information will provide consultants with greater confidence when referring their patients to receive treatment at home and outside of a hospital setting.
“This hybrid model of homecare and digital cancer care is truly transformative; we expect to demonstrate that it creates capacity and is also cost-effective, reducing drug wastage and unexpected acute hospital admissions.”
Dany Bell, strategic advisor to cancer charity Macmillan commented: “The current pandemic has had a devastating impact on cancer services around the UK. Disruption to diagnosis and treatment have created significant challenges for patients and healthcare professionals. Finding ways to better support people living with cancer whilst establishing continuity of care is crucial now and in the future.”
LloydsPharmacy Clinical Homecare is part of McKesson UK.
Date published: February 22, 2021